Withings, a company known for making clinical-grade health technology accessible to consumers, introduced two innovative products at CES 2025. These releases include the BPM Vision (a compact home blood pressure monitor that we saw it in person and it was already mentioned in our Best of CES 2025 article), and Cardio Check, a subscription-based heart monitoring service.
BPM Vision is a portable blood pressure monitor priced at $130, designed to make at-home health management more convenient. The device measures systolic and diastolic blood pressure with what Withings describes as “clinical accuracy.” It features interchangeable arm cuffs, a large display for ease of use, and Wi-Fi connectivity. A built-in battery ensures longevity, lasting up to a year on a single charge.
The monitor includes features to enhance usability, such as multiple cuff sizes and support for up to eight user profiles. This makes it ideal for households with multiple users who want to track their individual results. Data collected by the device syncs with the Withings app, enabling users to monitor their health trends over time. The device is slated for release in the U.S. in April, pending FDA approval.
Cardio Check, the second product unveiled, offers round-the-clock heart monitoring through the Withings+ subscription service. For $10 per month, users gain access to up to four cardiovascular checkups annually, including evaluations by board-certified cardiologists. The service aims to detect heart issues like atrial fibrillation (AFib) early, providing users with critical insights into their heart health.
Cardio Check is compatible with a range of Withings devices, including the ScanWatch, ScanWatch 2, ScanWatch Nova, ScanWatch Nova Brilliant, Body Scan scale, BPM Core, and the BeamO. The latter device was introduced at CES 2024.
Filed in . Read more about CES, CES 2025 and Health.
